CBCN Advocacy Gu ides: Tak ing Act ion on Canad

The proposed changes are intended to require drug manufacturers to reduce the price of their medications significantly. [...] It is still uncertain what the magnitude of these price reductions will be once the regulations are applied to therapies in the real-world. [...] What Is The Impact On Pat ients? Patient advocates have raised concerns about many of the proposed changes to the regulations. [...] This could lead to a reduction in the number of new cancer therapies that are available in Canada and limited access to clinical trials. [...] Contact the Minister of Health- Share your thoughts and opinions on the proposed changes and the impacts they could have on cancer patients with the Minister of Health.